StockData
Collegium Pharmaceutical, Inc logo

Collegium Pharmaceutical, Inc (COLL) stock

COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$25.55+0.12 (+0.47%)

Close on Nov 17, 2026Market cap $831.80MP/E 20.6Yield –

Collegium Pharmaceutical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Collegium Pharmaceutical's pe ratio was 20.0× on Nov 11, 2026, against 29.0× a year earlier. Over the last 5 years it ranged from 6.7× to 219.7×, with a median of 19.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202620.0×−8.8
2025Dec 31, 202528.8×+16.4
2024Dec 31, 202412.3×−192.9
2023Dec 29, 2023205.2×+185.9
2022Jul 29, 202219.3×+12.2
2021Dec 31, 20217.1×−33.7
2020Dec 31, 202040.9×–

More Collegium Pharmaceutical figures

See a number that looks wrong?